Skip to main content
Premium Trial:

Request an Annual Quote

Quest to Develop Diagnostics Using SomaLogic Aptamer Tech; Invests $15M in Firm

NEW YORK, May 9 (GenomeWeb News) - Quest Diagnostics will develop new diagnostic tests based on SomaLogic's proprietary aptamer array platform, the companies said last week.


Terms of the deal call for Quest to make a $15 million equity investment in SomaLogic. Additional terms of the arrangement were not disclosed. Timetables for test development were not provided.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.